Christopher Henderson
Fondateur chez Anagenesis Biotechnologies SAS
Postes actifs de Christopher Henderson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Anagenesis Biotechnologies SAS
 Anagenesis Biotechnologies SAS Medical/Nursing ServicesHealth Services Anagenesis Biotechnologies SAS operates as a preclinical-stage stem cell-based company. It focuses on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs. The firm offers cell therapy for genetic diseases and pharmacological drugs for genetic and age-related diseases. The company was founded by Jean-Yves Bonnefoy, Christopher Henderson, Thierry Noel, Olivier Pourquié, Marie Knockaert and Jérôme Chal on April 25, 2011 and is headquartered in Graffenstaden, France. | Directeur/Membre du Conseil | 25/04/2011 | - |
| Fondateur | 25/04/2011 | - |
Historique de carrière de Christopher Henderson
Anciens postes connus de Christopher Henderson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/10/2017 | 01/03/2020 |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Fondateur | 01/01/1991 | - |
Statistiques
Internationale
| France | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Anagenesis Biotechnologies SAS
Anagenesis Biotechnologies SAS Medical/Nursing ServicesHealth Services Anagenesis Biotechnologies SAS operates as a preclinical-stage stem cell-based company. It focuses on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs. The firm offers cell therapy for genetic diseases and pharmacological drugs for genetic and age-related diseases. The company was founded by Jean-Yves Bonnefoy, Christopher Henderson, Thierry Noel, Olivier Pourquié, Marie Knockaert and Jérôme Chal on April 25, 2011 and is headquartered in Graffenstaden, France. | Health Services |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
- Bourse
- Insiders
- Christopher Henderson
- Expérience
